C-Path Opportunities Table
Advancing Drug Development. Improving Lives. Together.
Forging New Paths in Prostate Cancer Treatment: How Dr. Peter Wipf and C-Path’s Translational Therapeutics Accelerator Are Driving Impact in Men’s Health
Dr. Peter Wipf, a renowned professor of chemistry at the University of Pittsburgh and one of the leading innovators in prostate cancer research, shares the impact the grant award from Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) has made, and the benefits of working with the TRxA team.
ALS Advocate Ron Newbury Pushes for Progress, Positivity Amidst Adversity
Ron Newbury is a former attorney, teacher, and a lifelong outdoor enthusiast. He was diagnosed with amyotrophic lateral sclerosis (ALS) in July of 2022. Like many living with ALS, he had years of unexplained symptoms before his diagnosis: a weakened golf swing, feeling his arms would tire quickly during routine tasks, and more. However, it was during one of his cherished bike trips that things progressed to the point of needing some answers.
Bending the Curve: Sarah Zenner-Dolan’s Advocacy Journey with Parkinson’s Disease
At Critical Path Institute's 20 Year Gala on Feb.10, 2025, Sarah Zenner-Dolan shared her personal mission and journey with Parkinson’s Disease, highlighting the importance of staying strong in the face of this challenging condition. As a 58-year-old woman living with Young Onset Parkinson’s Disease, Sarah’s story is a testament to resilience.
Strength in Service: A Young Mother’s Battle with ALS
In October of 2022, 38-year-old Melissa Diaz-Viera was a new mom to a happy eight-month-old baby and had recently recovered from a bout of COVID-19. At around that time she started experiencing mild impairments, such as pincer grasp weakness that made it difficult to use a pair of nail clippers, button her baby's clothes and use chopsticks. She also noticed some twitching in her thighs. By January of 2023, her symptoms had not subsided and it was time for a trip to her primary care physician.
How C-Path’s Biomarker Data Repository Brings Patients to the Table to Discuss Biomarkers and Their Impact
Innovative Model-informed Drug Development Tools to Inform Trial Design in Neurological Diseases
Driving Regulatory Progress for Inherited Ataxias: CPTA’s Impact in Advocacy and Change
Inherited ataxias are a diverse collection of genetic disorders that are characterized by clinical manifestations like impaired coordination of voluntary movements, such as gait and speech.
United Against Cancer: John Galas’ Impact on Sarcoma and Soccer
John Galas has spent most of his life around soccer. At an early age, he developed a deep passion for the sport and embraced the competitive spirit inherent in it. This mindset that proved invaluable when he faced his toughest opponent yet: cancer.
